Global /India /Healthcare /Drug Manufacturers - General /524314

Gujarat Terce Laboratories Ltd.

524314 (GUJTERC)

• BSE: 524314 • Delayed

38.00INR 2.7%

0.4030 USD

As of 25 June 2026, Gujarat Terce Laboratories Ltd. has a market cap of $3.12M USD, ranking #46064 globally and #4252 in India. It ranks #4083 in the Healthcare sector, and #1309 in the Drug Manufacturers - General industry.

Global Rank

46064

Country Rank

4252

Sector Rank

4083

Industry Rank

1309

Key Stats

Market Cap

$3.12MUSD

296.07M INR

Enterprise Value

$3.1MUSD

292.58M INR

Revenue (TTM)

$5.11MUSD

483.98M INR

EBITDA (TTM)

$431.16KUSD

40.66M INR

Net Income (TTM)

-$135.18KUSD

-12.81M INR

EBITDA Margin

8.4%

Profit Margin

-2.6%

PS Ratio

0.6

EV/EBITDA

7.2

Company Profile

Country (HQ)

India

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Aalap Prajapati open_in_new

Employees

244

Founded

1985

Website

gujaratterce.in open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
2.7%	-5.1%	12%	-20%	-25%	-15%	-41%	86%	394%

News

Markets

Exchange	Ticker	Price	Quotes
Bombay Stock Exchange (BSE / BOM) MIC: XBOM PRIMARY	524314 (GUJTERC) Gujarat Terce Laboratories Ltd ISIN: INE499G01013 Shares Out.: Shares Outstanding: 7.791M¹ TV: TradingView: BSE: GUJTERC SA: Stock Analysis: BOM: 524314 YF: Yahoo Finance: 524314.BO GF: Google Finance: BOM: 524314 BA: Barron's: 524314 MS: Morningstar: XBOM: 524314	38.00 INR	TV: TradingView: BSE: GUJTERC SA: Stock Analysis: BOM: 524314 YF: Yahoo Finance: 524314.BO GF: Google Finance: BOM: 524314 BA: Barron's: 524314 MS: Morningstar: XBOM: 524314

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Gujarat Terce Laboratories Ltd.

Gujarat Terce Laboratories Limited develops, manufactures, markets, and distributes medicines and healthcare products in India and internationally. The company offers generic pharmaceutical for therapeutic areas, such as antibiotics, respiratory, nutraceuticals, gastrology, gynecology, pain therapy, and ayurvedic. It provides tablets, capsules, oral liquids, ointments, and injections under the Acolate, Tynol, Resplash, Ferlit, Z-Oxi, Vitfol, Thyter, Aziter, Codimol, Cefter, and Terflora brands. Gujarat Terce Laboratories Limited was incorporated in 1985 and is based in Ahmedabad, India.

Similar Companies

Industry: Drug Manufacturers - General (India)

Name	Market Cap (USD) diff.	PE	Country
Sun Pharmaceutical Industries Ltd. NSE: SUNPHARMA	$45.04B 4.27T INR 1M%	39.1	India
Divi's Laboratories Ltd. NSE: DIVISLAB	$18.31B 1.73T INR 586K%	70.0	India
Torrent Pharmaceuticals Ltd. NSE: TORNTPHARM	$15.11B 1.43T INR 483K%	63.0	India
Dr. Reddy's Laboratories Ltd. NSE: DRREDDY	$11.69B 1.11T INR 374K%	19.6	India
Mankind Pharma Ltd. NSE: MANKIND	$9.83B 931.67B INR 315K%	52.2	India
Zydus Lifesciences Ltd. NSE: ZYDUSLIFE	$9.67B 916.53B INR 309K%	18.6	India

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 24M%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 18M%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 12M%	97.4	United States
Roche Holding AG SIX: RO	$316.37B 256.25B CHF 10M%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$284.33B 215.59B GBP 9M%	27.6	United Kingdom
Merck & Co., Inc. NYSE: MRK	$274.03B 9M%	15.1	United States

chevron_leftBack